Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Shares Outstanding (Cover Page)

2.8 / 5 stars · 68/120 Roast Me

ELI LILLY AND COMPANY Shares Outstanding (Cover Page)

ELI LILLY AND COMPANY (LLY) had Shares Outstanding (Cover Page) of 941.36 million shares as of 2026-08-03, per its 10-Q filed 2026-08-05.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05

  • 2026-08-03: Entity Common Stock, Shares Outstanding 941.36M shares.
  • 2026-04-27: Entity Common Stock, Shares Outstanding 941.74M shares.
  • 2026-02-09: Entity Common Stock, Shares Outstanding 943.36M shares.
  • 2025-10-27: Entity Common Stock, Shares Outstanding 945.38M shares.
Period endEntity Common Stock, Shares Outstanding
2026-08-03941.36M shares
10-Q · filed 2026-08-05
2026-04-27941.74M shares
10-Q · filed 2026-04-30
2026-02-09943.36M shares
10-K · filed 2026-02-12
2025-10-27945.38M shares
10-Q · filed 2025-10-30
2025-08-04946.46M shares
10-Q · filed 2025-08-07
2025-04-28947.74M shares
10-Q · filed 2025-05-01
2025-02-14948.17M shares
10-K · filed 2025-02-19
2024-10-25949.32M shares
10-Q · filed 2024-10-30
2024-08-05950.43M shares
10-Q · filed 2024-08-08
2024-04-25950.41M shares
10-Q · filed 2024-04-30
2024-02-16950.16M shares
10-K · filed 2024-02-21
2023-10-30949.31M shares
10-Q · filed 2023-11-02
2023-08-03949.30M shares
10-Q · filed 2023-08-08
2023-04-24949.27M shares
10-Q · filed 2023-04-27
2023-02-17950.30M shares
10-K · filed 2023-02-22
2022-10-28950.18M shares
10-Q · filed 2022-11-01
2022-08-01950.17M shares
10-Q · filed 2022-08-04
2022-04-26950.16M shares
10-Q · filed 2022-04-29
2022-02-18952.35M shares
10-K · filed 2022-02-23
2021-10-22956.59M shares
10-Q · filed 2021-10-27
2021-07-30956.58M shares
10-Q · filed 2021-08-03
2021-04-27959.03M shares
10-Q · filed 2021-04-30
2021-02-12958.43M shares
10-K · filed 2021-02-17
2020-10-26956.58M shares
10-Q · filed 2020-10-28
2020-07-27956.47M shares
10-Q · filed 2020-07-31
2020-04-27956.45M shares
10-Q · filed 2020-05-01
2020-02-13956.38M shares
10-K · filed 2020-02-19
2019-10-21960.13M shares
10-Q · filed 2019-10-25
2019-07-29965.43M shares
10-Q · filed 2019-08-02
2019-04-29970.83M shares
10-Q · filed 2019-05-02
2019-02-131.04B shares
10-K · filed 2019-02-19
2018-11-021.06B shares
10-Q · filed 2018-11-06
2018-07-231.07B shares
10-Q · filed 2018-07-25
2018-04-231.09B shares
10-Q · filed 2018-04-27
2018-02-141.10B shares
10-K · filed 2018-02-20
2017-10-231.10B shares
10-Q · filed 2017-10-27
2017-07-171.10B shares
10-Q · filed 2017-07-28
2017-04-241.10B shares
10-Q · filed 2017-05-01
2017-02-131.10B shares
10-K · filed 2017-02-21
2016-10-171.10B shares
10-Q · filed 2016-10-28
2016-07-181.10B shares
10-Q · filed 2016-07-28
2016-04-181.10B shares
10-Q · filed 2016-04-29
2016-02-121.11B shares
10-K · filed 2016-02-19
2015-10-191.11B shares
10-Q · filed 2015-10-30
2015-07-201.11B shares
10-Q · filed 2015-07-30
2015-04-201.11B shares
10-Q · filed 2015-04-30
2015-02-131.11B shares
10-K · filed 2015-02-19
2014-10-201.11B shares
10-Q · filed 2014-10-29
2014-07-211.12B shares
10-Q · filed 2014-07-28
2014-04-211.12B shares
10-Q · filed 2014-04-28
2014-02-141.12B shares
10-K · filed 2014-02-19
2013-10-231.13B shares
10-Q · filed 2013-10-30
2013-07-201.13B shares
10-Q · filed 2013-07-26
2013-04-201.13B shares
10-Q · filed 2013-04-26
2013-02-151.13B shares
10-K · filed 2013-02-21
2012-10-201.16B shares
10-Q · filed 2012-10-26
2012-07-201.16B shares
10-Q · filed 2012-07-27
2012-04-201.16B shares
10-Q · filed 2012-04-30
2012-02-151.16B shares
10-K · filed 2012-02-24
2011-10-201.16B shares
10-Q · filed 2011-10-28
2011-07-201.16B shares
10-Q · filed 2011-07-29
2011-04-201.16B shares
10-Q · filed 2011-04-29
2011-02-151.16B shares
10-K · filed 2011-02-22
2010-10-201.15B shares
10-Q · filed 2010-10-29
2010-07-201.15B shares
10-Q/A · filed 2010-08-02
2010-04-201.15B shares
10-Q · filed 2010-07-30
2010-02-121.15B shares
10-K · filed 2010-02-22
2009-10-201.15B shares
10-Q · filed 2009-10-30
2009-07-201.15B shares
10-Q · filed 2009-07-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94